NEW YORK (GenomeWeb) – Next-generation sequencing data firm OneOme has raised $1 million toward a targeted $5 million private financing round, it said in a document filed with the US Securities and Exchange Commission this week. 

The company said 15 investors had participated in the round but did not disclose their identities. OneOme CEO Troy Kopischke told GenomeWeb that the financing is the firm's first seed round and will help it accelerate the growth of its pharmacogenomics platform. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.